CRT

Macy's, Inc. (NYSE: M) is scheduled to announce first quarter financial results on Wednesday morning. A look at crowdsourced site Estimize provides a clear idea of what to expect. The company’s earnings respond to a cycle. Earnings tend to peak on the fourth quarter, and hit lows...

CRT cut its price target on Delta Air Lines, Inc. (NYSE: DAL) on Wednesday from $63 to $59, and maintained a Buy rating on the stock. Analysts Michael Derchin and Adam Hackel noted that the stock traded at 4.8 times its estimated 2016 TEV/EBITDAR, which was "at the low end of the historic...

Yelp Inc (NYSE: YELP) reported Q4 earnings on Thursday and issued guidance below consensus. Investors reacted by sending the stock down 21.51 percent Friday to $45.11. Analysts weighed in on the company following the earnings report. Below are highlights along with current ratings and price...

CRT reiterated its Buy rating and $150 price target on Edwards Lifesciences Corp (NYSE: EW) Wednesday following the company’s Q4 results. The company’s Q4 revenue grew 15 percent year-over-year to $618 million, beating consensus by by $9 million. EPS was up 12 percent year-over-year...

Barclays raised its price target on Valeant Pharmaceuticals Intl Inc (NYSE: VRX) from $149 to $179 Friday and maintained a Buy rating. Analyst David Steinberg noted that the “surprisingly strong rev guidance (implied 14-15 percent Y/Y growth) is ~$150M ahead of the co’s prior 3Q14...

CRT Capital raised its price target on Hawaiian Holdings, Inc. (NASDAQ: HA) from $27 to 31 Thursday and maintained a Buy rating. Analyst Michael Derchin noted that change is a “result of improving fundamentals.” The price target “assumes the stock trades at 5.5x estimated...

Williams-Sonoma, Inc. (NYSE: WSM) gained more than 9 percent Thursday on better-than-expected same-store sales, but a couple of analysts stuck with luke-warm ratings and suggested the shares are fairly valued. CRT's Lee J. Giordano called the San Francisco-based company "a high-quality...

CRT Capital upgraded Akorn, Inc. (NASDAQ: AKRX) from Fair Value to Buy with a $46 price target. Analyst Tim Chiang believed “the recent sell off in AKRX shares post 3Q results creates a potential buying opportunity, based on our view that the Company will benefit from solid pricing trends...

J C Penney Company Inc (NYSE: JCP) fell sharply Thursday after reporting mixed Q3 results and weak guidance. The stock traded at $7.11 Thursday, down 8.3 percent. Below are analysts comments on the company along with current ratings and price targets. Credit Suisse - Underperform, $7 price...

Zillow Inc (NASDAQ: Z) reported Q3 financial results Wednesday, beating EPS estimates but guiding Q4 lower. The stock responded by falling more 5 percent Thursday and recently traded at $98.04. Below are analyst comments on the Q3 results along with current ratings and price targets. J.P....

Facebook Inc (NASDAQ: FB) reported earnings Tuesday and surprised some investors by announcing an increase in spending. Shares fell approximately 6 percent Wednesday, trading at $75.86. Analysts were largely pleased with Facebook's decision to increase investment. Most modestly lowered...

Wall Street appeared comfortable with the latest big healthcare merger, this one the acquisition of Covidien (NYSE: COV) by Medtronic (NYSE: MDT), a deal which turns eyes to Johnson & Johnson (NYSE: JNJ). "We expect many investors will expect J&J to buy something in the cardiac...

Several analysts are hitting the sell button on Amedisys Inc. (NASDAQ: AMED) this morning. The stock is currently trading higher by 8.36%, at $29.01. The company reported earnings this morning, which generally missed estimates; they also lowered the FY 2010 EPS and revenue estimates. This is...